Genzyme Corporation

Genzyme Corporation is a biotechnology company that develops and produces medicines for rare and complex diseases. Founded in 1981, it focuses on treatments for conditions like genetic disorders, rare blood diseases, and other specialized health issues. The company utilizes advanced scientific techniques to create therapies that are often difficult to develop due to the small patient populations. Acquired by Sanofi in 2011, Genzyme remains a leader in providing innovative solutions for unmet medical needs, prioritizing research, development, and manufacturing of specialized medicines to improve patient outcomes worldwide.